Cardiology Devices - Saudi Arabia

The projected revenue in the Cardiology Devices market market in Saudi Arabia is expected to reach US$1.06bn in 2024.
The market is also projected to experience an annual growth rate (CAGR 2024-2029) of 5.84%, which will result in a market volume of US$1.41bn by 2029.
In comparison to other countries worldwide, the United States is anticipated to generate the highest revenue, amounting to US$25.77bn in 2024.
Saudi Arabia is witnessing a growing demand for innovative cardiology devices, driven by the country's commitment to improving healthcare infrastructure and access to advanced medical technologies.

Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Cardiology diagnostic & monitoring devices
Cardiology surgical devices
Implants such as pacemakers

Cardiology drugs
Cardiology supplements

The Cardiology Devices market in Saudi Arabia has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to the development of this market. Customer preferences in Saudi Arabia have played a key role in the growth of the Cardiology Devices market. The population in Saudi Arabia is becoming more aware of cardiovascular diseases and the importance of early detection and treatment. As a result, there is a growing demand for advanced cardiology devices that can accurately diagnose and monitor heart conditions. Customers in Saudi Arabia also value quality and reliability, which has led to an increased demand for internationally recognized brands in the cardiology devices market. Trends in the market have also contributed to its development in Saudi Arabia. Technological advancements have led to the introduction of innovative cardiology devices that are more accurate, efficient, and user-friendly. For example, wearable devices that can continuously monitor heart rate and detect irregularities have gained popularity among customers in Saudi Arabia. Additionally, there is a growing trend towards minimally invasive procedures, which require specialized cardiology devices. The adoption of these trends has further fueled the growth of the Cardiology Devices market in Saudi Arabia. Local special circumstances have also influenced the development of the Cardiology Devices market in Saudi Arabia. The government has been actively promoting healthcare initiatives and investing in the development of healthcare infrastructure. This has led to an increase in the number of hospitals and clinics equipped with advanced cardiology devices. Additionally, the growing prevalence of cardiovascular diseases in Saudi Arabia has created a need for more cardiology devices to meet the demand for diagnosis and treatment. Underlying macroeconomic factors have also played a role in the growth of the Cardiology Devices market in Saudi Arabia. The country has a high GDP per capita, which has increased the affordability of cardiology devices for customers. Additionally, the government's focus on diversifying the economy has led to increased investments in healthcare, including the cardiology devices sector. The stability of the Saudi Arabian economy and the favorable regulatory environment have also attracted international players to enter the market, further driving its growth. In conclusion, the Cardiology Devices market in Saudi Arabia has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing awareness of cardiovascular diseases, technological advancements, government initiatives, and favorable economic conditions have all contributed to the development of this market.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.